← FDA Drug Approvals (Drugs@FDA)

DASATINIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2026-09-11

Drug application

FDA Application #

ANDA219579

Application type

Abbreviated New Drug Application (Generic)

Brand name

DASATINIB

Generic name

Dasatinib

Active ingredients

DASATINIB

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MSN

First approval

2026-09-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown